These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5170866)

  • 1. The pharmacist's role in product selection.
    J Am Pharm Assoc; 1971 Apr; 11(4):181-99. PubMed ID: 5170866
    [No Abstract]   [Full Text] [Related]  

  • 2. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 3. Future shock: drug therapy and the U.S. pharmaceutical industry.
    Ellenhorn MJ
    J Clin Pharmacol; 1975; 15(5-6):385-400. PubMed ID: 1133216
    [No Abstract]   [Full Text] [Related]  

  • 4. Doctors are pivotal to prescription struggle.
    Chapman S
    Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688
    [No Abstract]   [Full Text] [Related]  

  • 5. Achieving a quality drug supply.
    Nelson G
    J Am Pharm Assoc; 1974 Oct; 14(10):548-9, 564. PubMed ID: 4420394
    [No Abstract]   [Full Text] [Related]  

  • 6. The plea of a Jacksonville druggist.
    JAMA; 1972 May; 220(6):853-4. PubMed ID: 5067354
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Drug costs and drug quality.
    Lasagna L
    Ann Intern Med; 1974 Aug; 81(2):261-2. PubMed ID: 4843580
    [No Abstract]   [Full Text] [Related]  

  • 8. Thalidomide and beyond: some recommendations regarding public policies toward the ethical drug industry.
    Schifrin LG
    Int J Health Serv; 1974; 4(1):147-55. PubMed ID: 4829893
    [No Abstract]   [Full Text] [Related]  

  • 9. Annual administrative reviews: pharmacy.
    Black HJ
    Hospitals; 1973 Apr; 47(7):153-5 passim. PubMed ID: 4573778
    [No Abstract]   [Full Text] [Related]  

  • 10. Today's dilemma--will drugs work?
    Dowling HF
    J Am Pharm Assoc; 1971 Jun; 11(6):331-3. PubMed ID: 5118797
    [No Abstract]   [Full Text] [Related]  

  • 11. The control of drugs and therapeutic freedom.
    Dunlop D
    Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
    [No Abstract]   [Full Text] [Related]  

  • 12. Benefits and liabilities of generic prescribing.
    Lee AM
    W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384
    [No Abstract]   [Full Text] [Related]  

  • 13. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 14. Standardization of drug names.
    Allan FM
    JAMA; 1974 Jul; 229(5):541-3. PubMed ID: 4406898
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic problems in drug distribution.
    Rucker TD
    Inquiry; 1972 Sep; 9(3):43-50. PubMed ID: 4262974
    [No Abstract]   [Full Text] [Related]  

  • 16. Who has an impact on collaborative drug therapy management legislation? Perceptions of state pharmacy association directors.
    Kutikova L; Reed PJ
    J Am Pharm Assoc (Wash); 2003; 43(2):261-4. PubMed ID: 12688441
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: The pharmacist and drug product selection.
    Tice LF
    Am J Pharm Sci Support Public Health; 1974; 146(3):67-9. PubMed ID: 4851580
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug combinations. A critique of proposed new federal regulations.
    McMahon FG
    JAMA; 1971 May; 216(6):1008-10. PubMed ID: 5108241
    [No Abstract]   [Full Text] [Related]  

  • 19. Customary and usual brand names.
    Sperber E
    N Engl J Med; 1969 Feb; 280(8):450. PubMed ID: 5763098
    [No Abstract]   [Full Text] [Related]  

  • 20. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.